Sun Ophthalmics

Manufacturing · United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Sun Ophthalmics

CEQUA offers cyclosporine ophthalmic solution 0.09% designed to treat chronic dry eye disease. Their product, Cyclosporine Eye Drops, aims to provide relief for individuals suffering from this condition. The intended clients are patients experiencing chronic dry eye symptoms. CEQUA focuses on delivering effective eye care solutions.Explore more
Popular SearchesSun OphthalmicsSun Pharmaceutical Industries IncSIC Code 28,283NAICS Code 32,325Show more

Is Sun Ophthalmics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Sun Ophthalmics

Compare insights from companies similar to Sun Ophthalmics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Sun Ophthalmics

<$5M
1-10
Private
-
-
N/A
$6.3M
11-50
Private
<$5M
2007
PB
Pamela BaxterDirector, Quality
$5.1M
11-50
Private
$24.6M
2004
CB
Carolynne BornhutterTraining Director, Human Resources
<$5M
11-50
Private
-
-
GS
Garry SouthanExecutive Vice President & Principal & Fellow
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Sun Ophthalmics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Sun Ophthalmics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sun Ophthalmics.

Sun Ophthalmics Tech Stack

A closer look at the technologies used by Sun Ophthalmics

Sun Ophthalmics News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Sun Ophthalmics

What is Sun Ophthalmics's official website?
Sun Ophthalmics's official website is www.cequapro.com
What is Sun Ophthalmics's Revenue?
Sun Ophthalmics's revenue is <$5 Million
What is Sun Ophthalmics's SIC code?
Sun Ophthalmics's SIC: 28,283
What is Sun Ophthalmics's NAICS code?
Sun Ophthalmics's NAICS: 32,325
How many employees does Sun Ophthalmics have?
Sun Ophthalmics has 1-10 employees
What industry does Sun Ophthalmics belong to?
Sun Ophthalmics is in the industry of: Manufacturing, Pharmaceuticals
What is Sun Ophthalmics competition?
Sun Ophthalmics top competitors include: Insite Vision, Dompé, Inotek Pharmaceuticals, Velesco Pharmaceutical Services
What technology does Sun Ophthalmics use?
Some of the popular technologies that Sun Ophthalmics uses are: reCAPTCHA, Adobe Activation, Google Tag Manager, GoDaddy DNS
What does Sun Ophthalmics do?

CEQUA offers cyclosporine ophthalmic solution 0.09% designed to treat chronic dry eye disease. Their product, Cyclosporine Eye Drops, aims to provide relief for individuals suffering from this condition. The intended clients are patients experiencing chronic dry eye symptoms. CEQUA focuses on delivering effective eye care solutions.... Read More

Is Sun Ophthalmics a public company?
Sun Ophthalmics is private company therefore does not currently have an official ticker symbol
See more information about Sun Ophthalmics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.